Clinical Trial Update: PEG-IFN Plus Ribavirin Combination Therapy for Older Patients [NA]

View source ↗

Summary

A clinical trial update examining PEG-IFN plus ribavirin for older patients with hepatitis C, with the current status of the study reported as unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis C

Drugs mentioned

• Pegylated interferon (pegylated interferon alfa)
• Ribavirin (ribavirin)

Snippet

Sponsor: Kyushu University | Conditions: Hepatitis C Virus | NA | Status: UNKNOWN